This unique and comprehensive collection investigates the challenges posed to intellectual property by recent paradigm shifts in biology. It explores the legal ramifications of emerging technologies, such as genomics, synthetic biology, stem cell research, nanotechnology, and biodiscovery.
Extensive contributions examine recent controversial court decisions in patent law - such as Bilski v. Kappos, and the litigation over Myriad's patents in respect of BRCA1 and BRCA2 - while other papers explore sui generis fields, such as access to genetic resources, plant breeders' rights, and traditional knowledge. The collection considers the potential and the risks of the new biology for global challenges - such as access to health-care, the protection of the environment and biodiversity, climate change, and food security. It also considers Big Science projects - such as biobanks, the 1000 Genomes Project, and the Doomsday Vault. The inter-disciplinary research brings together the work of scholars from Australia, Canada, Europe, the UK, and the US and involves not only legal analysis of case law and policy developments, but also historical, comparative, sociological, and ethical methodologies.
Intellectual Property and Emerging Technologies will appeal to policy makers, legal practitioners, business managers, inventors, scientists, and researchers.
Contributors include: A. Agovic, A. Bostanci, J. Calvert, G. Dutfield, D.M. Gitter, R. Gold, F. Hemmings, E. Hemmungs Wirten, S. Holcombe, T. Janke, P.-B. Joly, Y. Joly, A. McLennan, D. Nicol, M. Rimmer, J.D. Sarnoff
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
Edited by Matthew Rimmer, Professor of Intellectual Property and Innovation Law, Faculty of Business and Law, Queensland University of Technology (QUT) and Alison McLennan, Assistant Professor, School of Law & Justice, Faculty of Business, Government & Law, University of Canberra, Australia
Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.
Da: Basi6 International, Irving, TX, U.S.A.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Codice articolo ABEOCT25-222716
Quantità: 1 disponibili
Da: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.
Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide. Codice articolo ABBB-147201
Quantità: 1 disponibili
Da: Books Puddle, Woodside, NY, U.S.A.
Condizione: Used. pp. 512. Codice articolo 2697344100
Quantità: 1 disponibili
Da: Majestic Books, Hounslow, Regno Unito
Condizione: Used. pp. 512. Codice articolo 96134587
Quantità: 1 disponibili
Da: Biblios, Frankfurt am main, HESSE, Germania
Condizione: Used. pp. 512. Codice articolo 1897344110
Quantità: 1 disponibili
Da: Brook Bookstore On Demand, Napoli, NA, Italia
Condizione: new. Codice articolo c41b0a9003bc7f78929c6a841d16ed64
Quantità: 9 disponibili
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
Condizione: New. 2012. Hardcover. . . . . . Codice articolo V9781849802468
Quantità: 1 disponibili
Da: Ria Christie Collections, Uxbridge, Regno Unito
Condizione: New. In English. Codice articolo ria9781849802468_new
Quantità: 9 disponibili
Da: PBShop.store UK, Fairford, GLOS, Regno Unito
HRD. Condizione: New. New Book. Shipped from UK. Established seller since 2000. Codice articolo FW-9781849802468
Quantità: 10 disponibili
Da: Rarewaves.com USA, London, LONDO, Regno Unito
Hardback. Condizione: New. This unique and comprehensive collection investigates the challenges posed to intellectual property by recent paradigm shifts in biology. It explores the legal ramifications of emerging technologies, such as genomics, synthetic biology, stem cell research, nanotechnology, and biodiscovery. Extensive contributions examine recent controversial court decisions in patent law - such as Bilski v. Kappos, and the litigation over Myriad's patents in respect of BRCA1 and BRCA2 - while other papers explore sui generis fields, such as access to genetic resources, plant breeders' rights, and traditional knowledge. The collection considers the potential and the risks of the new biology for global challenges - such as access to health-care, the protection of the environment and biodiversity, climate change, and food security. It also considers Big Science projects - such as biobanks, the 1000 Genomes Project, and the Doomsday Vault. The inter-disciplinary research brings together the work of scholars from Australia, Canada, Europe, the UK, and the US and involves not only legal analysis of case law and policy developments, but also historical, comparative, sociological, and ethical methodologies. Intellectual Property and Emerging Technologies will appeal to policy makers, legal practitioners, business managers, inventors, scientists, and researchers. Contributors include: A. Agovic, A. Bostanci, J. Calvert, G. Dutfield, D.M. Gitter, R. Gold, F. Hemmings, E. Hemmungs Wirten, S. Holcombe, T. Janke, P.-B. Joly, Y. Joly, A. McLennan, D. Nicol, M. Rimmer, J.D. Sarnoff. Codice articolo LU-9781849802468
Quantità: 5 disponibili